These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 15263794

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [Abstract] [Full Text] [Related]

  • 4. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma.
    Lee SE, Kwak C, Byun SS, Gill MC, Chang IH, Kim YJ, Hong SK.
    Urol Int; 2006 Jul; 76(3):256-63. PubMed ID: 16601390
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
    Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, Belldegrun A.
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000.
    Gez E, Rubinov R, Gaitini D, Meretyk S, Best LA, Native O, Stein A, Erlich N, Beny A, Zidan J, Haim N, Kuten A.
    Cancer; 2002 Oct 15; 95(8):1644-9. PubMed ID: 12365011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Outcome of patients in metastatic renal cell carcinoma with or without embolization].
    Masuda F, Nakada J, Takasaka S, Hishinuma H.
    Hinyokika Kiyo; 1987 Sep 15; 33(9):1354-6. PubMed ID: 3434491
    [Abstract] [Full Text] [Related]

  • 12. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
    Franklin JR, Figlin R, Rauch J, Gitlitz B, Belldegrun A.
    Semin Urol Oncol; 1996 Nov 15; 14(4):230-6. PubMed ID: 8946623
    [Abstract] [Full Text] [Related]

  • 13. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
    Belldegrun A, Shvarts O, Figlin RA.
    Cancer J Sci Am; 2000 Feb 15; 6 Suppl 1():S88-92. PubMed ID: 10685666
    [Abstract] [Full Text] [Related]

  • 14. Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.
    Hofmockel G, Langer W, Theiss M, Gruss A, Frohmüller HG.
    J Urol; 1996 Jul 15; 156(1):18-21. PubMed ID: 8648791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
    Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, Lorusso V, Guida M.
    J Urol; 2005 Jan 15; 173(1):52-5. PubMed ID: 15592024
    [Abstract] [Full Text] [Related]

  • 18. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C, Park YH, Jeong CW, Jeong H, Lee SE, Moon KC, Ku JH.
    J Surg Oncol; 2007 Mar 15; 95(4):317-23. PubMed ID: 17066434
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.